Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New Approaches to the Treatment of Hypercortisolism.

Pofi R. et al, (2024), Annu Rev Med

Lessons to learn from the 2024 NICE guideline on adrenal insufficiency.

Dong J. and Tomlinson JW., (2024), Lancet Diabetes Endocrinol

Prospective cohort for early detection of liver cancer (Pearl): a study protocol.

Khanna K. et al, (2024), BMJ Open, 14

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans

Westcott F. et al, (2024), European Journal of Endocrinology (EJE)

Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain

Hodson D. et al, (2024)

Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.

Colosimo S. et al, (2024), Diabetes Res Clin Pract

Are we putting patients on steroid treatment at risk under anaesthesia?

Tomlinson JW., (2024), Anaesthesia

Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.

Efthymiadis A. et al, (2024), J Endocrinol Invest

Service evaluation suggests variation in clinical care provision in adults with congenital adrenal hyperplasia in the UK and Ireland.

Doyle LM. et al, (2024), Clin Endocrinol (Oxf)

Recruitment, Retention, and Training of Citizen Scientists in Translational Medicine Research: A Citizen Science Initiative on Non-Alcoholic Fatty Liver Disease.

Shah SGS. et al, (2024), Cureus, 16

Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.

Brennan PN. et al, (2024), Lancet Gastroenterol Hepatol

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction

Tomlinson JW., (2024), Diabetes, Obesity and Metabolism

Alterations in plasma protein N-glycosylation after caloric restriction and bariatric surgery.

Štambuk T. et al, (2024), Surg Obes Relat Dis

Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.

Miller H. et al, (2024), BMJ Open, 14

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.

Koutoukidis DA. et al, (2024), Gut microbes, 16

A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study.

Colosimo S. et al, (2023), Nutr Metab Cardiovasc Dis

Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets.

Liu J. et al, (2023), medRxiv

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

Pofi R. et al, (2023), Endocr Rev, 44, 975 - 1011

Multivariable Model to Predict an ACTH Stimulation Test to Diagnose Adrenal Insufficiency Using Previous Test Results.

Lawrence NR. et al, (2023), J Endocr Soc, 7

Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition.

Gómez C. et al, (2023), Br J Pharmacol

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?